Provided is a rosuvastatin triol and its use as a reference standard for analysis of rosuvastatin. (I)

The present invention provides a pharmaceutical composition comprising benazepril and amlodipine wherein the benazepril and the amlodipine are not physically separated from one another and methods for making the same.

The subject invention provides rasagiline tannate compositions and a process for manufacture thereof.

The present invention relates to solid crystalline Tigecycline and crystalline forms thereof.

Crystalline forms of Sitagliptin salts processes for preparing crystalline forms of Sitagliptin salts and pharmaceutical compositions of Sitagliptin salts are provided.

Disclosed are formulations which are designed to delay release of rasagiline while maintaining specific pharmacokinetic properties.

The subject invention provides a solid dispersion of rasagiline citrate a composition and a process for the manufacture thereof.

Una forma cristalina de aripiprazol II caracterizada por al menos uno de un patrón de XRD que tiene picos a 165 187 219 224 y 235 grados dos-theta ±02 grados dos-theta o un barrido de DSC que muestra una endoterma ancha y pequeña en el intervalo de aproximadamente 100 ºC a aproximadamente 130 ºC y una endoterma de fusión a de aproximadamente 148 ºC a aproximadamente 150 ºC y que tiene menos de un 20 % en peso del compuesto cristalino 1 compuesto cristalino 2 forma cristalina C o forma cristalina...

Atorvastatin potassium crystalline Forms A B E F and G are provided. Also provided are methods of preparing atorvastatin potassium crystalline Forms A B E F and G. Atorvastatin potassium crystalline Forms A B E F and G may be used to prepare pharmaceutical compositions useful for the treatment of hypercholesterolemia or hyperlipidemia.